Yahoo Web Search

  1. Ad

    related to: What factors predict disease-free period in mammary tumors in dogs?
  2. No Appointment Needed. No Waiting. Ask a Vet for Info So Your Dog Can Feel Better Faster.

Search results

      • In univariate analysis, tumour characteristics such as size, mode of growth, regional lymph node metastases, tumour cell MIB-1 LI and MMP-9 and uPA expressions in tumour-adjacent fibroblasts, were associated with both survival and disease-free intervals.
      www.ncbi.nlm.nih.gov › pmc › articles
  1. People also ask

  2. Jan 4, 2013 · In multivariable analysis, only a MIB-1 labelling index higher than 40% and a stromal expression of MMP-9 higher than 50% retained significant relationships with poor overall and disease-free survival. The results of this study indicate that MMP-9 and Ki-67 are independent prognostic markers of canine malignant mammary tumours.

    • Andreia A Santos, Célia C Lopes, Jorge R Ribeiro, Liliana R Martins, Joana C Santos, Irina F Amorim,...
    • 2013
  3. Aug 4, 2023 · Prognostic Factors for Cancer-Specific Survival and Disease-Free Interval of Dogs with Mammary Carcinomas - PMC. Journal List. Vet Med Int. v.2023; 2023. PMC10421712. As a library, NLM provides access to scientific literature.

    • 10.1155/2023/6890707
    • 2023
    • Vet Med Int. 2023; 2023: 6890707.
  4. Aug 4, 2023 · Analysis of maximum likelihood estimates of multivariate logistic regression to predict the probability of overall survival and disease-free interval for at least 1 year after surgery in dogs affected by mammary tumor.

  5. Oct 31, 2018 · A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.

    • Ana Canadas, Miguel França, Cristina Pereira, Raquel Vilaça, Hugo Vilhena, Flora Tinoco, Maria João ...
    • 2019
  6. Aug 4, 2023 · Canine mammary tumors (CMTs) are the most diagnosed neoplasms in dogs; however, there are few studies analyzing the influence of epidemiological, clinicopathological, and histopathological data on cancer-specific survival (CSS), disease-free interval (DFI), and overall survival (OS) in a large cohor ….

  7. Nov 5, 2019 · Clinical and histological prognostic factors for mammary tumors have been previously studied and have been suggested to be important parameters in determining the possible outcome and progression of the disease ( 3, 12 ). The most important clinical characteristics are tumor size, lymph node status and the presence of distant metastasis ( 13 ).

  8. Mar 29, 2017 · The prognosis was even worse for adenosquamous carcinoma (MST = 18 months), comedocarcinoma (MST = 14 months), and solid carcinoma (MST = 8 months). The most unfavorable outcome was for anaplastic carcinoma (MST = 3 months) and carcinosarcoma (MST = 3 months), which also had the highest metastatic rates (89% and 100%, respectively).

  1. People also search for